Request for TOC Request for Sample
BUY NOW

U.S. Soft Tissue Repair Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

Healthcare | Upcoming Report | May 2021 | Country Level | 350 Pages | No of Tables: 60 | No of Figures: 220
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

U S Soft Tissue Repair Market

Market Size in USD Billion

CAGR :  %

USD 2.60 Billion USD 4.60 Billion 2024 2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD 2.60 Billion
Market Size (Forecast Year)
USD 4.60 Billion
CAGR
%
Major Markets Players
  • Stryker (U.S.)
  • Zimmer Biomet (U.S.)
  • Medtronic (Ireland)
  • DePuy Synthes (U.S.)
  • CONMED Corporation (U.S.)

U.S. Soft Tissue Repair Market Segmentation, By Product (Tissue Patch/Mesh, Fixation Devices and Laparoscopic Instruments), Application (Orthopaedic Surgery, Breast Reconstruction, Hernia Repair, Skin Repair, Vaginal Sling Repair, Cardiovascular Surgery, Dental Reconstruction and Others), End User (Hospitals, Ambulatory Surgical Centres, Clinics and Others)- Industry Trends and Forecast to 2032

U.S. Soft Tissue Repair Market Size

  • The U.S. soft tissue repair market size was valued at USD 2.60 billion in 2024 and is expected to reach USD 4.60 billion by 2032, at a CAGR of 7.4% during the forecast period
  • The market growth is largely fueled by the increasing prevalence of soft tissue injuries from sports activities, trauma, and an aging population, coupled with advancements in minimally invasive surgical techniques and innovative biomaterials
  • Furthermore, rising demand for effective, reliable, and specialized surgical solutions across orthopedic, hernia, breast reconstruction, and cardiovascular applications is establishing soft tissue repair as a key segment in the U.S. surgical market. These converging factors are accelerating the adoption of soft tissue repair procedures, thereby significantly boosting the industry's growth

U.S. Soft Tissue Repair Market Analysis

  • Soft tissue repair, encompassing surgical procedures and medical devices for repairing muscles, tendons, ligaments, and other connective tissues, is increasingly critical in orthopedic, hernia, breast reconstruction, and cardiovascular surgeries due to rising injury prevalence, aging populations, and advances in minimally invasive techniques
  • The escalating demand for soft tissue repair solutions is primarily fueled by increasing sports-related injuries, trauma cases, and technological innovations in biomaterials, surgical implants, and fixation devices that enhance recovery and procedural outcomes
  • The U.S. market benefited from advanced healthcare infrastructure, high healthcare expenditure, and strong research & development capabilities among leading players such as Medtronic, Johnson & Johnson, Stryker, and Smith & Nephew, with significant adoption of innovative surgical techniques and devices in hospitals and specialty clinics
  • Growing integration of biologics, regenerative medicine approaches, and scaffold-based repair solutions is improving procedural efficacy and patient outcomes, encouraging wider adoption across healthcare facilities
  • Fixation devices segment dominated the U.S. soft tissue repair market with a market share of 47.2% in 2024, driven by their effectiveness in minimally invasive procedures and ability to support faster patient recovery

Report Scope and U.S. Soft Tissue Repair Market Segmentation         

Attributes

U.S. Soft Tissue Repair Key Market Insights

Segments Covered

  • By Product: Tissue Patch/Mesh, Fixation Devices and Laparoscopic Instruments
  • By Application: Orthopaedic Surgery, Breast Reconstruction, Hernia Repair, Skin Repair, Vaginal Sling Repair, Cardiovascular Surgery, Dental Reconstruction and Others
  • By End User: Hospitals, Ambulatory Surgical Centres, Clinics and Others

Countries Covered

  •  U.S.

Key Market Players

  • Stryker (U.S.)
  • Zimmer Biomet (U.S.)
  • Medtronic (Ireland)
  • DePuy Synthes (U.S.)
  • CONMED Corporation (U.S.)
  • Integra LifeSciences Corporation. (U.S.)
  • Bioventus (U.S.)
  • Orthofix Medical Inc. (U.S.)
  • RTI Surgical (U.S.)
  • KARL STORZ (Germany)
  • MedShape Solutions (U.S.)
  • Biocomposites (U.K.)
  • OrthAlign (U.S.)
  • Mitek Sports Medicine (U.S.)
  • Acera Surgical (U.S.)
  • Arthrex (U.S.)
  • FlexiSuture Innovations (U.S.)
  • Smith+Nephew (U.K.)
  • Johnson & Johnson MedTech (U.S.)

Market Opportunities

  • Rising adoption of regenerative medicine and biologic implants
  • Increasing demand for minimally invasive and outpatient surgical procedures

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

U.S. Soft Tissue Repair Market Trends

“Increasing Adoption of Minimally Invasive and Robotic-Assisted Procedures”

  • A significant and accelerating trend in the U.S. soft tissue repair market is the growing adoption of minimally invasive and robotic-assisted surgical techniques, which improve precision, reduce recovery time, and enhance patient outcomes
  • For instance, robotic-assisted systems such as the Mako SmartRobotics platform are being used in orthopedic soft tissue repairs to enable precise implant positioning and soft tissue balancing, reducing post-surgical complications
  • Surgeons are increasingly utilizing advanced laparoscopic instruments and image-guided technologies, allowing for smaller incisions, less tissue trauma, and faster rehabilitation for patients
  • Integration of real-time imaging, navigation systems, and robotic assistance facilitates more accurate repairs in complex cases such as ligament reconstruction or hernia repair
  • This trend toward advanced, less invasive procedures is reshaping patient and physician expectations, prompting medical device companies such as Stryker and Medtronic to invest in next-generation surgical tools and robotics
  • The demand for minimally invasive and robotic-assisted soft tissue repair procedures is rising across hospitals and specialty surgical centers, driven by improved patient satisfaction and reduced hospital stays

U.S. Soft Tissue Repair Market Dynamics

Driver

“Rising Incidence of Sports Injuries and Trauma Cases”

  • The increasing prevalence of sports-related injuries, workplace accidents, and trauma cases is a major driver fueling the demand for soft tissue repair solutions in the U.S.
  • For instance, a surge in anterior cruciate ligament (ACL) injuries among athletes has led hospitals and clinics to adopt advanced fixation devices and tissue grafts for efficient repairs
  • Growing awareness of early intervention and effective surgical treatments is prompting patients and physicians to choose soft tissue repair procedures over conservative management
  • Technological advancements in surgical implants, biologics, and scaffold-based repair solutions are enabling better outcomes and supporting the rising procedural volume
  • Collaboration between hospitals, sports organizations, and research institutions is driving adoption of advanced repair techniques for injury prevention and treatment
  • Development of customized implants and patient-specific solutions using 3D printing technology is enhancing surgical precision and boosting market demand
  • High healthcare expenditure and increasing insurance coverage for soft tissue repair procedures encourage wider adoption across hospitals and ambulatory surgical centers

Restraint/Challenge

“High Procedure Costs and Regulatory Compliance Requirements”

  • The relatively high cost of advanced soft tissue repair devices, surgical procedures, and associated hospital stays is a significant restraint on market growth, particularly for uninsured or underinsured patients
  • For instance, robotic-assisted soft tissue repair procedures can cost significantly more than traditional surgeries, limiting accessibility in price-sensitive segments
  • Stringent regulatory requirements and approvals from the FDA for new implants, biologics, and surgical instruments can delay product launches and add to operational costs
  • Insurance reimbursement variability across states and procedure types further complicates adoption, particularly for novel devices and minimally invasive techniques
  • Limited surgeon availability and the need for specialized training for advanced procedures can slow adoption rates in certain regions
  • Potential complications and post-operative risks associated with complex repairs may discourage some patients and healthcare providers from opting for advanced procedures
  • Overcoming these challenges through cost optimization, expanded insurance coverage, and streamlined regulatory pathways will be critical for sustained growth in the U.S. soft tissue repair market

U.S. Soft Tissue Repair Market Scope

The market is segmented on the basis of product, application, and end user.

  • By Product

On the basis of product, the U.S. soft tissue repair market is segmented into tissue patch/mesh, fixation devices, and laparoscopic instruments. The fixation devices segment dominated the market with the largest market revenue share of 47.2% in 2024, driven by their critical role in stabilizing soft tissues during orthopedic, hernia, and ligament repair procedures. Hospitals and surgical centers prioritize fixation devices due to their proven effectiveness in enhancing surgical precision and reducing recovery time. The segment’s dominance is also supported by ongoing innovations in bioabsorbable and modular fixation solutions, which allow surgeons to customize repairs based on patient needs. Increased prevalence of musculoskeletal injuries and sports-related trauma further reinforces demand. Surgeons and healthcare providers often prefer fixation devices for minimally invasive procedures as they provide reliable outcomes with lower complication rates. Market growth is In addition fueled by the strong presence of leading medical device companies in the U.S., which continuously launch technologically advanced fixation products.

The tissue patch/mesh segment is anticipated to witness the fastest growth rate from 2025 to 2032, driven by the rising prevalence of hernia repairs, breast reconstruction surgeries, and cardiovascular procedures requiring soft tissue reinforcement. Tissue patches and meshes offer biocompatibility, enhanced healing, and reduced post-operative complications, making them highly sought after in modern surgical procedures. Advancements in synthetic and biologic meshes have further expanded their applicability across multiple surgical domains. Increasing awareness among surgeons about the benefits of minimally invasive implantation techniques is also boosting adoption. The growing preference for outpatient and ambulatory surgical procedures encourages the use of lightweight, easy-to-implant meshes. In addition, research and development efforts by key manufacturers to introduce next-generation, infection-resistant, and regenerative meshes are accelerating market expansion.

  • By Application

On the basis of application, the U.S. soft tissue repair market is segmented into orthopedic surgery, breast reconstruction, hernia repair, skin repair, vaginal sling repair, cardiovascular surgery, dental reconstruction, and others. The orthopedic surgery segment dominated the market in 2024, driven by the high incidence of musculoskeletal injuries and ligament tears requiring surgical intervention. Hospitals and specialized orthopedic centers heavily rely on advanced fixation devices and laparoscopic instruments for reconstructive procedures, contributing to segment growth. Increasing sports participation and a rising geriatric population prone to joint injuries also support demand. Technological advancements such as minimally invasive arthroscopic techniques and robotic-assisted repairs further enhance procedural efficiency and patient outcomes. Adoption of preoperative planning software and 3D-printed implants in orthopedic procedures is increasing surgical accuracy, reinforcing market dominance. Insurance coverage and reimbursement policies for orthopedic surgeries in the U.S. make these procedures more accessible to patients, supporting consistent segment growth.

The hernia repair segment is expected to witness the fastest CAGR from 2025 to 2032 due to increasing prevalence of abdominal wall defects and rising demand for laparoscopic and mesh-based repairs. Surgeons prefer laparoscopic instruments and biocompatible meshes for minimally invasive hernia repairs, which reduce patient recovery time and postoperative complications. The trend toward outpatient hernia surgeries and same-day procedures drives adoption in ambulatory surgical centers. Rising awareness among patients and healthcare providers about the advantages of advanced soft tissue repair products further fuels demand. Continuous product innovations, including lightweight, infection-resistant meshes, are expanding the market potential. Collaborations between medical device companies and hospitals for surgical training programs are also accelerating adoption rates.

  • By End User

On the basis of end user, the U.S. soft tissue repair market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment dominated the market in 2024, reflecting the concentration of specialized surgical facilities, skilled surgeons, and advanced medical infrastructure. Hospitals handle complex soft tissue repair procedures, including orthopedic, hernia, and cardiovascular surgeries, which require sophisticated fixation devices and laparoscopic instruments. They also lead in the adoption of minimally invasive and robotic-assisted techniques. High patient volumes, strong insurance coverage, and R&D collaborations with medical device manufacturers further drive the dominance of hospitals. Hospitals’ ability to implement multi-disciplinary approaches and integrated surgical workflows ensures higher procedural success rates. Growing investments in surgical infrastructure and training programs continue to support the segment’s leading position.

The ambulatory surgical centers segment is expected to witness the fastest growth from 2025 to 2032 due to increasing preference for outpatient soft tissue repair procedures. These centers offer cost-effective, convenient, and timely surgical care, particularly for minimally invasive orthopedic and hernia repairs. Rising patient awareness and insurance incentives for outpatient surgeries are contributing to this growth. The adoption of lightweight fixation devices, advanced meshes, and portable laparoscopic instruments makes these centers increasingly capable of performing complex repairs efficiently. Expansion of specialized surgical networks and partnerships with hospitals is also enhancing the capabilities of ambulatory surgical centers. Growth is further supported by the trend toward shorter hospital stays and faster patient recovery, which aligns with the operational model of these centers.

U.S. Soft Tissue Repair Market Share

The U.S. Soft Tissue Repair industry is primarily led by well-established companies, including:

  • Stryker (U.S.)
  • Zimmer Biomet (U.S.)
  • Medtronic (Ireland)
  • DePuy Synthes (U.S.)
  • CONMED Corporation (U.S.)
  • Integra LifeSciences Corporation. (U.S.)
  • Bioventus (U.S.)
  • Orthofix Medical Inc. (U.S.)
  • RTI Surgical (U.S.)
  • KARL STORZ (Germany)
  • MedShape Solutions (U.S.)
  • Biocomposites (U.K.)
  • OrthAlign (U.S.)
  • Mitek Sports Medicine (U.S.)
  • Acera Surgical (U.S.)
  • Arthrex (U.S.)
  • FlexiSuture Innovations (U.S.)
  • Smith+Nephew (U.K.)
  • Johnson & Johnson MedTech (U.S.)

What are the Recent Developments in U.S. Soft Tissue Repair Market?

  • In October 2025, Smith+Nephew announced plans to launch its ALLEVYN COMPLETE CARE 5-layer foam dressing in the U.S. advanced wound care market, designed for pressure injury prevention and wound management. The ALLEVYN COMPLETE CARE Dressing demonstrated an increased Frictional Energy Absorber Effectiveness, up from 30-45% to 93%
  • In September 2025, Austin-based FlexiSuture Innovations launched a laser-activated adhesive technology for sutureless soft tissue repairs, aiming to reduce surgical complications and enhance healing. FlexiSuture's core innovation is a laser-activated adhesive system for sutureless soft tissue repair. This approach leverages laser-activated adhesives to accelerate healing, reduce surgical complications, and improve patient outcomes
  • In June 2025, Acera Surgical received FDA 510(k) clearance for Restrata, a fully synthetic, resorbable electrospun matrix, expanding its clinical applications to include soft tissue reinforcement in addition to wound healing. This advancement broadens the clinical utility of the Restrata platform, now supporting soft tissue reinforcement applications in addition to its previously cleared indications for wound healing
  • In May 2025, Arthrex obtained FDA clearance for its non-absorbable SuturePatch Tissue Reinforcement device, designed to reinforce soft tissue repairs in orthopedic surgeries. The SuturePatch is a non-absorbable, permanent, implantable orthopedic surgical mesh intended for the reinforcement of soft tissue/tendon repair
  • In March 2025, Johnson & Johnson MedTech highlighted its advancements in digital orthopaedics at the AAOS 2025 conference, focusing on innovations across joint reconstruction, trauma, and spine surgeries. These developments are grounded in the company’s commitment to deliver innovative, impactful solutions that address the evolving needs of surgeons and patient


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future